Valuation: QuidelOrtho Corporation

Market Cap 1.14B 994M 925M 850M 1.6B 109B 1.63B 10.91B 4.28B 54.35B 4.29B 4.2B 182B P/E 2026 *
-10.5x
P/E 2027 * -105x
Enterprise Value 3.51B 3.05B 2.84B 2.61B 4.93B 335B 5B 33.5B 13.15B 167B 13.19B 12.9B 560B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.24x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+1.21%
1 week+4.49%
1 month-7.76%
3 months+32.67%
6 months-38.28%
Current year-41.28%
1 week 16
Extreme 16
17.51
1 month 15.49
Extreme 15.49
19.03
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.79
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Tech/Sci/R&D Officer 44 2024-10-06
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+1.21%+4.49%-26.48%-80.29% 1.14B
-1.89%-1.36%+19.78%-40.36% 15.7B
+4.47%+7.46%+3.82%+107.97% 1.77B
-1.73%+2.33%-33.93%+16.19% 980M
+1.29%+7.31%-44.39%-52.50% 655M
+0.93%+7.41%-45.64%-53.16% 543M
+1.08%+2.47%+55.85%-51.37% 472M
-0.81%+1.33%-52.64%-61.03% 374M
-0.81%+5.14%-13.72%-32.63% 368M
+4.84%+12.18%+24.77%+21.00% 329M
Average +0.86%+3.50%-11.26%-22.62% 2.23B
Weighted average by Cap. -0.86%-0.01%+9.39%-28.36%

Financials

2026 *2027 *
Net sales 2.71B 2.35B 2.19B 2.01B 3.8B 258B 3.85B 25.8B 10.13B 129B 10.16B 9.94B 431B 2.78B 2.42B 2.25B 2.06B 3.9B 265B 3.96B 26.5B 10.4B 132B 10.43B 10.21B 443B
Net income -156M -135M -126M -116M -219M -14.88B -222M -1.49B -583M -7.41B -585M -572M -24.83B -81.93M -71.22M -66.29M -60.87M -115M -7.82B -117M -781M -307M -3.89B -308M -301M -13.06B
Net Debt 2.37B 2.06B 1.92B 1.76B 3.32B 226B 3.37B 22.59B 8.87B 113B 8.9B 8.7B 378B 2.3B 2B 1.86B 1.71B 3.22B 219B 3.27B 21.92B 8.6B 109B 8.63B 8.44B 366B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-31 US$16.77 +1.21% 739,537
26-07-30 US$16.57 +0.42% 1,216,768
26-07-29 US$16.50 -1.02% 1,188,025
26-07-28 US$16.67 -0.95% 989,723
26-07-27 US$16.83 +4.86% 1,057,029
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
16.77USD
Average target price
21.33USD
Spread / Average Target
+27.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock